These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38450511)
21. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. Inaba T; Matsuda M; Shimamura M; Takei N; Terasaka N; Ando Y; Yasumo H; Koishi R; Makishima M; Shimomura I J Biol Chem; 2003 Jun; 278(24):21344-51. PubMed ID: 12672813 [TBL] [Abstract][Full Text] [Related]
22. The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells. Chen PY; Chao TY; Hsu HJ; Wang CY; Lin CY; Gao WY; Wu MJ; Yen JH Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576019 [TBL] [Abstract][Full Text] [Related]
23. Tissue-specific epigenetics of atherosclerosis-related ANGPT and ANGPTL genes. Ehrlich KC; Lacey M; Ehrlich M Epigenomics; 2019 Feb; 11(2):169-186. PubMed ID: 30688091 [TBL] [Abstract][Full Text] [Related]
24. Post-GWAS methodologies for localisation of functional non-coding variants: ANGPTL3. Oldoni F; Palmen J; Giambartolomei C; Howard P; Drenos F; Plagnol V; Humphries SE; Talmud PJ; Smith AJ Atherosclerosis; 2016 Mar; 246():193-201. PubMed ID: 26800306 [TBL] [Abstract][Full Text] [Related]
25. Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3). Ginsberg HN; Goldberg IJ Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):388-398. PubMed ID: 36579649 [TBL] [Abstract][Full Text] [Related]
26. ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation. Zhao T; Liang X; Chen J; Bao Y; Wang A; Gan X; Lu X; Wang L Biochem Biophys Res Commun; 2019 Aug; 516(3):880-887. PubMed ID: 31270029 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides. Graham MJ; Lee RG; Brandt TA; Tai LJ; Fu W; Peralta R; Yu R; Hurh E; Paz E; McEvoy BW; Baker BF; Pham NC; Digenio A; Hughes SG; Geary RS; Witztum JL; Crooke RM; Tsimikas S N Engl J Med; 2017 Jul; 377(3):222-232. PubMed ID: 28538111 [TBL] [Abstract][Full Text] [Related]
28. Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage. Lv Q; Han X; Ni J; Ma Q; Dai R; Liu J; Liu J; Zhai Y; Shen Q; Sun L; Liu H; Rao J; Xu H Cell Death Dis; 2022 Oct; 13(10):867. PubMed ID: 36229446 [TBL] [Abstract][Full Text] [Related]
33. Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3. Watts GF; Raal FJ; Chan DC Future Cardiol; 2022 Feb; 18(2):143-153. PubMed ID: 34651521 [TBL] [Abstract][Full Text] [Related]
34. Structure and Function of Angiopoietin-like Protein 3 (ANGPTL3) in Atherosclerosis. Lu X Curr Med Chem; 2020; 27(31):5159-5174. PubMed ID: 31223079 [TBL] [Abstract][Full Text] [Related]
35. The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone. Fugier C; Tousaint JJ; Prieur X; Plateroti M; Samarut J; Delerive P J Biol Chem; 2006 Apr; 281(17):11553-9. PubMed ID: 16505486 [TBL] [Abstract][Full Text] [Related]
36. Angiopoietin-like 3 regulates hepatocyte proliferation and lipid metabolism in zebrafish. Lee SH; So JH; Kim HT; Choi JH; Lee MS; Choi SY; Kim CH; Kim MJ Biochem Biophys Res Commun; 2014 Apr; 446(4):1237-42. PubMed ID: 24685482 [TBL] [Abstract][Full Text] [Related]
37. Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3. Zimerman A; Wiviott SD; Park JG; Murphy SA; Ran X; Bramson CR; Curto M; Ramos V; Jevne A; Kuder JF; Verma S; Wojakowski W; Terra SG; Sabatine MS; Bergmark BA; Marston NA J Clin Lipidol; 2024; 18(2):e261-e268. PubMed ID: 38158248 [TBL] [Abstract][Full Text] [Related]
38. Impact of oral lipid and glucose tolerance tests on the postprandial concentrations of angiopoietin-like proteins (Angptl) 3 and 4. Schmid A; Belikan H; Höpfinger A; Schäffler A; Karrasch T Eur J Nutr; 2022 Jun; 61(4):1919-1929. PubMed ID: 34951653 [TBL] [Abstract][Full Text] [Related]
40. Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Qiu M; Glass Z; Chen J; Haas M; Jin X; Zhao X; Rui X; Ye Z; Li Y; Zhang F; Xu Q Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]